| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/12/2012 | CA2824063A1 Hydrophobic molecule-induced branched polymer aggregates and their use |
| 07/12/2012 | CA2823747A1 Liposome formulation suitable for treating or preventing tuberculosis |
| 07/12/2012 | CA2823628A1 Spray drying vancomycin |
| 07/12/2012 | CA2822481A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide |
| 07/12/2012 | CA2819988A1 O/w-emulsions comprising semifluorinated alkanes |
| 07/12/2012 | CA2819234A1 Pharmaceutical compositions of iron for oral administration |
| 07/11/2012 | EP2474613A1 Methods and compositions |
| 07/11/2012 | EP2474582A1 Coating agent comprising hydroxyalkyl cellulose |
| 07/11/2012 | EP2474559A1 Hydroxypropyl cellulose particles |
| 07/11/2012 | EP2474558A1 New antibiotic containing simulacrum antibody, preparation method and application thereof |
| 07/11/2012 | EP2474557A2 Anti-CD79b antibodies and immunoconjugates and methods of use |
| 07/11/2012 | EP2474324A1 Coating composition |
| 07/11/2012 | EP2474309A1 Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same |
| 07/11/2012 | EP2474307A2 Proliposomal drug delivery system |
| 07/11/2012 | EP2474306A1 Particle composition and medicinal composition comprising same |
| 07/11/2012 | EP2474298A1 Novel liquid crystal composition |
| 07/11/2012 | EP2473550A1 Silicone modified fatty acids, method of preparation and usage thereof |
| 07/11/2012 | EP2473523A2 Methods and compositions for the inhibition of transplant rejection |
| 07/11/2012 | EP2473521A2 B7-h4 fusion proteins and methods of use thereof |
| 07/11/2012 | EP2473197A2 Drug activation system |
| 07/11/2012 | EP2473196A2 Sdf-1 delivery for treating ischemic tissue |
| 07/11/2012 | EP2473195A2 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| 07/11/2012 | EP2473194A1 Stable formulation of factor viii |
| 07/11/2012 | EP2473191A1 Antibody coformulations |
| 07/11/2012 | EP2473182A2 Targeted delivery using tissue-specific peptidomimetic ligands |
| 07/11/2012 | EP2473161A2 Topical formulations comprising a steroid |
| 07/11/2012 | EP2473157A1 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 07/11/2012 | EP2473044A1 Tocotrienol compositions |
| 07/11/2012 | EP2293785B1 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 07/11/2012 | EP2196477B1 Modified recombinant human endostatin and its application |
| 07/11/2012 | EP1732609B1 Conjugates of hydroxyalkyl starch and a protein |
| 07/11/2012 | EP1630136B1 Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same |
| 07/11/2012 | EP1626748B1 Moisture curable materials for delivery of agents, methods, and medical devices |
| 07/11/2012 | EP1567188B1 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 07/11/2012 | EP1282428B1 Biocompatible macromers |
| 07/11/2012 | EP1131052B1 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 07/11/2012 | CN202314484U Rosiglitazone maleate gastrointestinal mini-tablet capsule |
| 07/11/2012 | CN202314482U 布洛芬定时释药三层片 The timing of release of ibuprofen three-piece |
| 07/11/2012 | CN202314480U 一种改进型消风止痒颗粒 An improved particle Xiaofeng itching |
| 07/11/2012 | CN1805731B Composition and device for enhancing dosing efficiency |
| 07/11/2012 | CN1762381B Ophthalmic compositions containing galactomannan polymers and borate |
| 07/11/2012 | CN102574761A Use of vanillin derivatives as a preservative, preservation method, compounds, and composition |
| 07/11/2012 | CN102573923A Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 07/11/2012 | CN102573922A Targeted immunoconjugates |
| 07/11/2012 | CN102573921A Oligomer-calcimimetic conjugates and related compounds |
| 07/11/2012 | CN102573920A Glycopolysialylation of non-blood coagulation proteins |
| 07/11/2012 | CN102573919A Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 07/11/2012 | CN102573918A Oligomer-opioid agonist conjugates |
| 07/11/2012 | CN102573917A Pegylated L-asparaginase |
| 07/11/2012 | CN102573916A Uses of immunoconjugates targeting cd138 |
| 07/11/2012 | CN102573915A Influenza hemagglutinin compositions and uses thereof |
| 07/11/2012 | CN102573914A Porphyrin nanovesicles |
| 07/11/2012 | CN102573913A Biodegradable polyethylene glycol based water-insoluble hydrogels |
| 07/11/2012 | CN102573912A Method for improving the aqueous solubility of poorly-soluble substances |
| 07/11/2012 | CN102573910A Targeted nano-photomedicines for photodynamic therapy of cancer |
| 07/11/2012 | CN102573888A Long-acting Y2 receptor agonists |
| 07/11/2012 | CN102573849A Medicinal composition for iontophoresis |
| 07/11/2012 | CN102573843A Transdermally absorbable donepezil-containing preparation |
| 07/11/2012 | CN102573816A Low ether composition and delivery apparatus |
| 07/11/2012 | CN102573814A Polymer vesicles of asymmetric membrane |
| 07/11/2012 | CN102573813A 持续药物传递系统 Sustained drug delivery system |
| 07/11/2012 | CN102573811A Sustained release dosage form |
| 07/11/2012 | CN102573799A Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
| 07/11/2012 | CN102573796A Oral liquid formulation comprising salbutamol and guaifenesin |
| 07/11/2012 | CN102573793A Transdermal pharmaceutical preparations |
| 07/11/2012 | CN102573770A Isopropyl methyl phenol-containing liquid composition for oral cavity |
| 07/11/2012 | CN102573518A A xylitol containing comestible product |
| 07/11/2012 | CN102573517A Stable thickener formulations |
| 07/11/2012 | CN102560733A Preparation of double-medicine-carrying system based on PLGA (poly(lactide-co-glycolide))-LAP (Laponite) composite nano fiber |
| 07/11/2012 | CN102559725A Human stem cell growth factor as well as production method and application of polyethylene glycol (PEG) modified human stem cell growth factor |
| 07/11/2012 | CN102559714A Gene for coding catalase as well as preparation method and application thereof |
| 07/11/2012 | CN102559644A Antidotes for factor XA inhibitors and methods of using the same |
| 07/11/2012 | CN102559111A Styrene-series hot-melt pressure-sensitive adhesive and preparation method |
| 07/11/2012 | CN102558569A Lipopolysaccharide amine cationic polymer and preparation method and application thereof |
| 07/11/2012 | CN102558565A Polyethylene glycol monomethyl ether-polycaprolactone-polyphosphate copolymer and application thereof |
| 07/11/2012 | CN102558546A Polyethylene glycol glycyrrhetinic acid ester, composite drug-loaded micelle and preparation method and application thereof |
| 07/11/2012 | CN102558535A Amphiphilic block copolymer connected through molecular glue and synthesis method and application of copolymer |
| 07/11/2012 | CN102558524A Block copolymer of polyethylene glycol and polyester containing cyclic ether side groups and application thereof |
| 07/11/2012 | CN102558464A Preparation method of star block copolymer temperature-sensitive nanomicelle |
| 07/11/2012 | CN102558394A Preparation method of hydroxypropyl-beta-cyclodextrin |
| 07/11/2012 | CN102558391A Vitamin E succinate-chitosan graft and preparation method and application thereof |
| 07/11/2012 | CN102558363A Polypeptide carrier for improving medicament/gene tumor targeting and transfection efficiency and application |
| 07/11/2012 | CN102558362A Fusion protein for treating diabetes and preparation method for fusion protein |
| 07/11/2012 | CN102558361A Novel antibiotic containing antibiotic analogue and preparation method and application thereof |
| 07/11/2012 | CN102558360A Trypsin inhibitor and preparation method and application thereof |
| 07/11/2012 | CN102558359A Recombinant fusion toxin VEGF165-melittin and preparation method and application thereof |
| 07/11/2012 | CN102558358A Preparation and application of human fibroblast growth factor 21 fusion protein and mutant of human fibroblast growth factor 21 fusion protein |
| 07/11/2012 | CN102558352A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 07/11/2012 | CN102558337A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 07/11/2012 | CN102558334A Peptides that selectively home to heart vasculature and related conjugates and methods |
| 07/11/2012 | CN102558308A Carrier polypeptide for forming medical compositions and preparation method and application of carrier polypeptide |
| 07/11/2012 | CN102558300A Polypeptides capable of antagonizing corticotropin-releasing factor receptors 1 and application of polypeptides |
| 07/11/2012 | CN102558158A Hairpin polyamide modified by or free of beta-hydroxyl-gamma-amino acid and preparation method and application |
| 07/11/2012 | CN102557398A Boron-containing nano-mesoporous and macroporous bioactive glass, and preparation method and application thereof |
| 07/11/2012 | CN102553660A Composite of lamellar bimetal hydroxide and magnetic substrate and preparation thereof |
| 07/11/2012 | CN102553499A Method for preparing microcapsules based on low-ester pectin and calcium ion gelatinization and application of microcapsules |
| 07/11/2012 | CN102552987A Biological material in liquid at 4 DEG C and solid at 37 DEG C and preparation method and application |
| 07/11/2012 | CN102552972A Metal ion decoration meso pore silicon oxide and preparation method thereof |
| 07/11/2012 | CN102552950A Production process of unstable chemical injection |
| 07/11/2012 | CN102552947A Cation microvesicle and preparation method thereof |